NCT04662151: A trial that was reported late by Airway Therapeutics, Inc.
This trial was previously reported as an Applicable Clinical Trial, but is no longer.
Full data
| Full entry on ClinicalTrials.gov | NCT04662151 |
|---|---|
| Title | A Phase 1b/2, Randomized, Open-Label, Dose-Determined Study Evaluating the Safety, Tolerability, and Efficacy Profile of Intervention With AT-100 (rhSP-D) in Preterm Neonates at High Risk for the Development of Bronchopulmonary Dysplasia (BPD) |
| Results Status | no-longer-act |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Jan. 31, 2021 |
| Completion date | Feb. 28, 2023 |
| Required reporting date | Feb. 28, 2024, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | April 2, 2021 |
| Days late | None |